Biotechnology Archives - RamaOnHealthcare

Pharma / Biotech: Biotechnology

Read recent healthcare news on biotechnology in healthcare. Stay current on trends with our daily newsletter. Also, research insights with our curated search portal.

Value Assessment And Decision Making In The Face Of Uncertainty

2022-01-26T20:49:52-05:00

Health Affairs January 26, 2022

Value Assessment And Decision Making In The Face Of Uncertainty2022-01-26T20:49:52-05:00

Global Vaccine Inequity Led To The COVID-19 Omicron Variant: It’s Time For Collective Action

2022-01-26T20:46:09-05:00

Health Affairs January 26, 2022

Global Vaccine Inequity Led To The COVID-19 Omicron Variant: It’s Time For Collective Action2022-01-26T20:46:09-05:00

How Google’s early bet, 23andMe, has paid off

2022-01-26T20:31:35-05:00

Becker's Healthcare January 26, 2022

How Google’s early bet, 23andMe, has paid off2022-01-26T20:31:35-05:00

BioNTech and Google invest in AI biotech company’s $100M round

2022-01-26T20:30:50-05:00

Becker's Healthcare January 26, 2022

BioNTech and Google invest in AI biotech company’s $100M round2022-01-26T20:30:50-05:00

Merck vs. Pfizer’s COVID-19 antiviral pills: 11 notes

2022-01-26T20:29:56-05:00

Becker's Healthcare January 26, 2022

Merck vs. Pfizer’s COVID-19 antiviral pills: 11 notes2022-01-26T20:29:56-05:00

The Biden administration used billions in hospital Covid-19 funds to pay drugmakers

2022-01-26T19:56:02-05:00

STAT January 26, 2022

The Biden administration used billions in hospital Covid-19 funds to pay drugmakers2022-01-26T19:56:02-05:00

Early research suggests cancer drug could help flush HIV from its hiding spots

2022-01-26T19:54:52-05:00

STAT January 26, 2022

Early research suggests cancer drug could help flush HIV from its hiding spots2022-01-26T19:54:52-05:00

Panelists Explore What Exactly Is Holding Up US Adoption of Biosimilars

2022-01-26T17:42:08-05:00

AJMC January 26, 2022

Panelists Explore What Exactly Is Holding Up US Adoption of Biosimilars2022-01-26T17:42:08-05:00

A biotech wins the first FDA drug approval in a rare type of eye cancer

2022-01-26T17:32:36-05:00

BioPharma Dive January 26, 2022

A biotech wins the first FDA drug approval in a rare type of eye cancer2022-01-26T17:32:36-05:00

CRISPR: Maximizing this Revolutionary Genetic Tool While Minimizing IP Risk

2022-01-26T15:40:20-05:00

Pharmaceutical Executive January 26, 2022

CRISPR: Maximizing this Revolutionary Genetic Tool While Minimizing IP Risk2022-01-26T15:40:20-05:00

Concerns Mount Over Limited Evidence for Accelerated Approvals

2022-01-26T15:39:13-05:00

Pharmaceutical Executive January 26, 2022

Concerns Mount Over Limited Evidence for Accelerated Approvals2022-01-26T15:39:13-05:00

70% of healthcare execs expect M&A activity to rise this year

2022-01-26T12:44:47-05:00

McKnight's January 26, 2022

70% of healthcare execs expect M&A activity to rise this year2022-01-26T12:44:47-05:00

US vs EU: How can Europe translate home-grown innovation into biotech success?

2022-01-26T12:41:44-05:00

pharmaphorum January 26, 2022

US vs EU: How can Europe translate home-grown innovation into biotech success?2022-01-26T12:41:44-05:00

J&J eyes “tuck-in deals” as consumer health spinoff nears

2022-01-26T12:40:49-05:00

pharmaphorum January 26, 2022

J&J eyes “tuck-in deals” as consumer health spinoff nears2022-01-26T12:40:49-05:00

How partnerships help create more resilient and collaborative health systems

2022-01-26T12:29:57-05:00

World Economic Forum January 26, 2022

How partnerships help create more resilient and collaborative health systems2022-01-26T12:29:57-05:00

The Certainty Of Uncertainty In Health Technology Assessment

2022-01-26T12:20:46-05:00

Health Affairs January 26, 2022

The Certainty Of Uncertainty In Health Technology Assessment2022-01-26T12:20:46-05:00

Expect more mergers and acquisitions in healthcare and life sciences, KPMG says

2022-01-25T20:36:50-05:00

Chief Healthcare Executive January 25, 2022

Expect more mergers and acquisitions in healthcare and life sciences, KPMG says2022-01-25T20:36:50-05:00

New research links genes to a longer human lifespan

2022-01-25T19:54:28-05:00

Medical Xpress January 25, 2022

New research links genes to a longer human lifespan2022-01-25T19:54:28-05:00

Gene editing startup Metagenomi raises $175M to advance research pipeline

2022-01-25T17:41:47-05:00

BioPharma Dive January 25, 2022

Gene editing startup Metagenomi raises $175M to advance research pipeline2022-01-25T17:41:47-05:00

This Stem Cell Manufacturing Startup Just Raised An $80 Million War Chest To Revolutionize Medicine

2022-01-25T17:40:54-05:00

Forbes January 25, 2022

This Stem Cell Manufacturing Startup Just Raised An $80 Million War Chest To Revolutionize Medicine2022-01-25T17:40:54-05:00

J&J ‘constantly looking’ at biotech M&A, but focused on small, mid-sized deals

2022-01-25T16:53:50-05:00

BioPharma Dive January 25, 2022

J&J ‘constantly looking’ at biotech M&A, but focused on small, mid-sized deals2022-01-25T16:53:50-05:00

One of Google’s earliest genetic experiments, 23andMe, paid off — here’s what will make or break its future

2022-01-25T15:58:22-05:00

CNBC January 25, 2022

One of Google’s earliest genetic experiments, 23andMe, paid off — here’s what will make or break its future2022-01-25T15:58:22-05:00

Following Janssen flu deal, Leyden Labs gets $140M led by Casdin Capital and GV

2022-01-25T15:37:36-05:00

MedCity News January 25, 2022

Following Janssen flu deal, Leyden Labs gets $140M led by Casdin Capital and GV2022-01-25T15:37:36-05:00

Iowa’s institutions on the leading edge of next-gen vaccines and therapies

2022-01-24T21:15:07-05:00

BioPharma Dive January 24, 2022

Iowa’s institutions on the leading edge of next-gen vaccines and therapies2022-01-24T21:15:07-05:00